Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
NEW YORK, Sept. 7, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0610889/Clinical-Trial-Recruitment-in-Autoimmune-Disorders-Average-Patient-Recruitment-Per-Trial-has-Continued-to-Decline-Over-the-Past-Decade.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Summary
GBI Research, the leading business intelligence provider, has released its latest research "Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment per Trial has Continued to Decline Over the Past Decade" which provides an insight into clinical trial and patient recruitment in Autoimmune Disorders. The report examines different aspects concerning clinical trial and patient recruitment. The report analyzes the number of clinical trials and the number of patients recruited for five major indications such as Multiple Sclerosis, Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis and Psoriasis. It provides information about the total number of clinical trials conducted, by stage of development, geography, major sponsors and trails conducted per year. Analysis on the total number of patients recruited and the average number of patients recruited per each trial is also provided. The report analyzes the total number of patients recruited by stage of development, geography, major sponsors and trails conducted per year from 2000 to 2009. The average number of patients recruited by stage of development per year is also covered. For Brazil, China and India, an estimate of the prevalence population has also been provided for the years 2010 to 2017 across the five major Autoimmune Disorders.
Autoimmune Disorders represent a collective group of disorders which primarily arise due to an overactive immune response of the body against substances and tissues normally present within the body. Major clinical trial recruitment is conducted for Rheumatoid Arthritis. The numbers of clinical trials and patients recruited for this disease are 230 and 19,087 respectively. The average number of patients recruited per trial is highest for Rheumatoid Arthritis when compared to that of other indications.
Scope
- The report covers clinical trials, patient recruitment, average patient recruitment and prevalence population estimation for five major autoimmune disorders. The prevalence estimates is done for countries such as Brazil, India and China.
- The report covers different types of study designs and challenges faced in clinical trial recruitment as a whole.
- Status of Clinical Trials: It covers clinical trials for five major indications by stage of development, by sponsor, by geography and clinical trials conducted per year.
- Status of Patient Recruitment: It includes patient recruitment for five major indications by stage of development, by sponsor, by geography and clinical trials conducted per year. The report emphasizes on the average number of patients recruited per trial by stage of development and by year.
- Prevalence Population Estimation: The estimation for the years 2010 to 2017 gives an idea about the prevalence of the five major indications in the future.
Reasons to buy
The report will assist business development and marketing executives to strategize their product launches, by allowing them to -
- Develop a better study design for better patient recruitment.
- Plan an effective clinical trial recruitment management by understanding the trend of clinical trials and patient recruitment conducted for five major Autoimmune Disorders for the period 2000 to 2009
- Understand the clinical trial trend across the globe for major indications in Autoimmune Disorders which covers an in-depth analysis on clinical trials by Phase, by sponsor, by geography and by year.
- Understand the trend of patient recruitment across the globe for major indications in Autoimmune Disorders which covers an in-depth analysis on patient recruitment by Phase, by sponsor, by geography and by year.
- Know the top companies that conducted highest clinical trial recruitment by indication and Develop key strategic initiatives by studying the key strategies of top competitors
- Know the clinical trial recruitment share in autoimmune Disorders across the globe.
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 9
2 Clinical Trial Recruitment in Autoimmune Disorders- Introduction 12
2.1 GBI Report Guidance 13
3 Clinical Trail and Patient Recruitment- Overview 14
3.1 Effect of Clinical Trial Study Design on Patient Recruitment 14
3.1.1 Types of Study Designs 14
3.2 Current Challenges in Clinical Trial Recruitment and Enrollment 15
3.2.1 Challenges in Clinical Trials Due to Stringent Inclusive & Exclusive Criteria 15
3.2.2 Challenges in Clinical Research- Volunteer Perspective 16
4 Clinical Trial Recruitment in Autoimmune Disorders- Overview 17
4.1 Clinical Trial Share by Therapeutic Area 17
4.2 Clinical Trials for the Five Major Indications in Autoimmune Disorders 18
4.3 Patient Recruitment for the Five Major Indications in Autoimmune Disorders 19
4.4 Major Indications in Autoimmune Disorders 20
5 Clinical Trials and Patient Recruitment for Multiple Sclerosis 21
5.1 Multiple Sclerosis- Overview 21
5.2 Clinical Trials for Multiple Sclerosis 23
5.2.1 Number of Clinical Trials by Stage of Development 23
5.2.2 Number of Clinical Trials by Sponsor 24
5.2.3 Number of Clinical Trials by Geography 25
5.2.4 Number of Clinical Trials per Year 26
5.3 Patient Recruitment for Multiple Sclerosis 27
5.3.1 Number of Patients Recruited by Stage of Development 27
5.3.2 Number of Patients Recruited by Sponsor 28
5.3.3 Number of Patients Recruited by Geography 29
5.3.4 Number of Patients Recruited per Year 30
5.4 Average Number of Patients Recruited per Trial 31
5.4.1 Average Number of Patients Recruited per Trial by Stage of Development 31
5.4.2 Average Number of Patients Recruited per Trial per Year 32
5.5 Prevalence Population for Multiple Sclerosis in Brazil, China and India 33
5.5.1 Prevalence Population for Multiple Sclerosis in Brazil (2010-2017) 33
5.5.2 Prevalence Population for Multiple Sclerosis in China (2010-2017) 34
5.5.3 Prevalence Population for Multiple Sclerosis India (2010-2017) 35
6 Clinical Trials and Patient Recruitment for Rheumatoid Arthritis 36
6.1 Rheumatoid Arthritis- Overview 36
6.2 Clinical Trials for Rheumatoid Arthritis 37
6.2.1 Number of Clinical Trials by Stage of Development 37
6.2.2 Number of Clinical Trials by Sponsor 38
6.2.3 Number of Clinical Trials by Geography 39
6.2.4 Number of Clinical Trials by Year 40
6.3 Patient Recruitment for Rheumatoid Arthritis 41
6.3.1 Number of Patients Recruited by Stage of Development 41
6.3.2 Number of Patients Recruited by Sponsor 42
6.3.3 Number of Patients Recruited by Geography 43
6.3.4 Number of Patients Recruited by Year 44
6.4 Average Number of Patients Recruited per Trial 45
6.4.1 Average Number of Patients Recruited per Trial by Stage of Development 45
6.4.2 Average Number of Patients Recruited per Trial per Year 46
6.5 Prevalence Population for Rheumatoid Arthritis in Brazil, China and India 47
6.5.1 Prevalence Population for Rheumatoid Arthritis in Brazil (2010-2017) 47
6.5.2 Prevalence Population for Rheumatoid Arthritis in China (2010-2017) 48
6.5.3 Prevalence Population for Rheumatoid Arthritis India (2010-2017) 49
7 Clinical Trials and Patient Recruitment for Crohn's Disease 50
7.1 Crohn's Disease- Overview 50
7.2 Clinical Trials for Crohn's Disease 51
7.2.1 Number of Clinical Trials by Stage of Development 51
7.2.2 Number of Clinical Trials by Sponsor 52
7.2.3 Number of Clinical Trials by Geography 53
7.2.4 Number of Clinical Trials by Year 54
7.3 Patient Recruitment for Crohn's Disease 55
7.3.1 Number of Patients Recruited by Stage of Development 55
7.3.2 Number of Patients Recruited by Sponsor 56
7.3.3 Number of Patients Recruited by Geography 57
7.3.4 Number of Patients Recruited by Year 58
7.4 Average Number of Patients Recruited per Trial 59
7.4.1 Average Number of Patients Recruited per Trial by Stage of Development 59
7.4.2 Average Number of Patients Recruited per Trial per Year 60
7.5 Prevalence Population for Crohn's Disease in Brazil, China and India 61
7.5.1 Prevalence Population for Crohn's Disease in Brazil (2010-2017) 61
7.5.2 Prevalence Population for Crohn's Disease in China (2010-2017) 62
7.5.3 Prevalence Population for Crohn's Disease India (2010-2017) 63
8 Clinical Trials and Patient Recruitment for Ulcerative Colitis 64
8.1 Ulcerative Colitis- Overview 64
8.2 Clinical Trials for Ulcerative Colitis 65
8.2.1 Number of Clinical Trials by Stage of Development 65
8.2.2 Number of Clinical Trials by Sponsor 66
8.2.3 Number of Clinical Trials by Geography 67
8.2.4 Number of Clinical Trials by Year 68
8.3 Patient Recruitment for Ulcerative Colitis 69
8.3.1 Number of Patients Recruited by Stage of Development 69
8.3.2 Number of Patients Recruited by Sponsor 70
8.3.3 Number of Patients Recruited by Geography 71
8.3.4 Number of Patients Recruited by Year 72
8.4 Average Number of Patients Recruited per Trial 73
8.4.1 Average Number of Patients Recruited per Trial by Stage of Development 73
8.4.2 Average Number of Patients Recruited per Trial per Year 74
8.5 Prevalence Population for Ulcerative Colitis in Brazil, China and India 75
8.5.1 Prevalence Population for Ulcerative Colitis in Brazil (2010-2017) 75
8.5.2 Prevalence Population for Ulcerative Colitis in China (2010-2017) 76
8.5.3 Prevalence Population for Ulcerative Colitis India (2010-2017) 77
9 Clinical Trials and Patient Recruitment for Psoriasis 78
9.1 Psoriasis- Overview 78
9.2 Clinical Trials for Psoriasis 79
9.2.1 Number of Clinical Trials by Stage of Development 79
9.2.2 Number of Clinical Trials by Sponsor 80
9.2.3 Number of Clinical Trials by Geography 81
9.2.4 Number of Clinical Trials by Year 82
9.3 Patient Recruitment for Psoriasis 83
9.3.1 Number of Patients Recruited by Stage of Development 83
9.3.2 Number of Patients Recruited by Sponsor 84
9.3.3 Number of Patients Recruited by Geography 85
9.3.4 Number of Patients Recruited by Year 86
9.4 Average Number of Patients Recruited per Trial 87
9.4.1 Average Number of Patients Recruited per Trial by Stage of Development 87
9.4.2 Average Number of Patients Recruited per Trial per Year 88
9.5 Prevalence Population for Psoriasis in Brazil, China and India 89
9.5.1 Prevalence Population for Psoriasis in Brazil (2010-2017) 89
9.5.2 Prevalence Population for Psoriasis in China (2010-2017) 90
9.5.3 Prevalence Population for Psoriasis India (2010-2017) 91
10 Appendix 92
10.1 Market Definitions 92
10.2 Abbreviations 92
10.3 Research Methodology 92
10.3.1 Clinical Trials Overview 93
10.3.2 Number of Clinical Trials 93
10.3.3 Patient Recruitment Status 93
10.3.4 Prevalence of Disease in India, China and Brazil (2010-2017) 93
10.3.5 Primary Research 93
10.3.6 Expert Panel Validation 94
10.4 Contact Us 94
10.5 Disclaimer 94
10.6 Sources 95
1.1 List of Tables
Table 1: Clinical Trial Recruitment in Autoimmune Disorders, Global, Total Number of Clinical Trials by Therapeutic Area, 2000-2009 17
Table 2: Clinical Trial Recruitment in Autoimmune Disorders, Total Number of Clinical Trials for Major Indications, 2000-2009 18
Table 3: Clinical Trial Recruitment in Autoimmune Disorders, Total Number of Patients Recruited for 5 Major Indications, 2000-2009 19
Table 4: Clinical Trial Recruitment in Autoimmune Disorders, Number of Pipeline products in Phase III, 2010 20
Table 5: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Stage of Development , 2000-2009 23
Table 6: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Major Sponsors, 2000-2009 24
Table 7: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Geography, 2000-2009 25
Table 8: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials per Year, 2001-2009 26
Table 9: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Stage of Development, 2000-2009 27
Table 10: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Major Sponsors, 2000-2009 28
Table 11: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Geography, 2000-2009 29
Table 12: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited per Year, 2001-2009 30
Table 13: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 32
Table 14: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Average Number of Patients Recruited per Trial per Year, 2001-2009 32
Table 15: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), Brazil, 2010-2017 33
Table 16: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), China, 2010-2017 34
Table 17: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), India, 2010-2017 35
Table 18: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Stage of Development, 2000-2009 37
Table 19: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Major Sponsors, 2000-2009 38
Table 20: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Geography, 2000-2009 39
Table 21: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials per Year, 2000-2009 40
Table 22: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Stage of Development, 2000-2009 41
Table 23: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Major Sponsors, 2000-2009 42
Table 24: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Geography, 2000-2009 43
Table 25: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited per Year, 2000-2009 44
Table 26: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 46
Table 27: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Average Number of Patients Recruited per Trial per Year, 2000-2009 46
Table 28: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), Brazil, 2010-2017 47
Table 29: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), China, 2010-2017 48
Table 30: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), India, 2010-2017 49
Table 31: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Stage of Development, 2000-2009 51
Table 32: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Major Sponsors, 2000-2009 52
Table 33: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Geography, 2000-2009 53
Table 34: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials per Year, 2000-2009 54
Table 35: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited by Stage of Development, 2000-2009 55
Table 36: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients recruited by Major Sponsors, 2000-2009 56
Table 37: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited by Geography, 2000-2009 57
Table 38: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited per Year, 2000-2009 58
Table 39: Clinical Trial Recruitment in Autoimmune Disorders Crohn's Disease, Average Number of Patients Recruited per Trial by Stage of Development,2000-2009 59
Table 40: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Average Number of Patients Recruited per Trial per Year, 2000-2009 60
Table 41: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Prevalence Population (in Thousands), Brazil, 2010-2017 61
Table 42: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's DiseaseDisorder, Prevalence Population (in Thousands), China, 2010-2017 62
Table 43: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Prevalence Population (in Thousands), India, 2010-2017 63
Table 44: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Stage of Development, 2000-2009 65
Table 45: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Major Sponsors, 2000-2009 66
Table 46: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Geography, 2000-2009 67
Table 47: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, , Total Number of Clinical Trials per Year, 2000-2009 68
Table 48: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Stage of Development, 2000-2009 69
Table 49: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Major Sponsors, 2000-2009 70
Table 50: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Geography, 2000-2009 71
Table 51: Clinical Trial Recruitment in Auto Immune Disorders, Ulcerative Colitis, Total Number of Patients Recruited per Year, 2000-2009 72
Table 52: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Average Number of Patients Recruited per Trial by Stage of Development,2000-2009 73
Table 53: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Average Number of Patients Recruited per Trial per Year, 2000-2009 74
Table 54: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), Brazil, 2010-2017 75
Table 55: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), China, 2010-2017 76
Table 56: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), India, 2010-2017 77
Table 57: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Stage of Development, 2000-2009 79
Table 58: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Major Sponsors, 2000-2009 80
Table 59: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Geography, 2000-2009 81
Table 60: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials per Year, 2000-2009 82
Table 61: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Stage of Development, 2000-2009 83
Table 62: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Major Sponsors, 2000-2009 84
Table 63: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Geography, 2000-2009 85
Table 64: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited per Year, 2000-2009 86
Table 65: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 87
Table 66: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Average Number of Patients Recruited per Trial per Year, 2000-2009 88
Table 67: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), Brazil, 2010-2017 89
Table 68: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), China, 2010-2017 90
Table 69: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), India, 2010-2017 91
1.2 List of Figures
Figure 1: Clinical Trial Recruitment in Autoimmune Disorders, Global, Total Number of Clinical Trials by Therapeutic Area, 2000-2009 17
Figure 2: Clinical Trial Recruitment in Autoimmune Disorders, Total Number of Clinical Trials for Major Indications, 2000-2009 18
Figure 3: Clinical Trial Recruitment in Autoimmune Disorders, Total Number of Patients Recruited for the 5 Major Indications, 2000-2009 19
Figure 4: Clinical Trial Recruitment in Autoimmune Disorders, Number of Pipeline products in Phase III, 2010 20
Figure 5: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Stage of Development, 2000-2009 23
Figure 6: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Major Sponsors, 2000-2009 24
Figure 7: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Geography, 2000-2009 25
Figure 8: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials per Year, 2001-2009 26
Figure 9: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Stage of Development, 2000-2009 27
Figure 10: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Major Sponsors, 2000-2009 28
Figure 11: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Geography, 2000-2009 29
Figure 12: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited per Year, 2001-2009 30
Figure 13: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Average Number of Patients Recruited per Trial by Stage of Development,2000-2009 31
Figure 14: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Average Number of Patients Recruited per Trial per Year, 2001-2009 32
Figure 15: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), Brazil, 2010-2017 33
Figure 16: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), China, 2010-2017 34
Figure 17: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), India, 2010-2017 35
Figure 18: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Stage of Development, 2000-2009 37
Figure 19: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Major Sponsors, 2000-2009 38
Figure 20: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Geography, 2000-2009 39
Figure 21: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials per Year, 2000-2009 40
Figure 22: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Stage of Development, 2000-2009 41
Figure 23: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Major Sponsors, 2000-2009 42
Figure 24: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Geography, 2000-2009 43
Figure 25: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited per Year, 2000-2009 44
Figure 26: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 45
Figure 27: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Average Number of Patients Recruited per Trial per Year, 2000-2009 46
Figure 28: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), Brazil, 2010-2017 47
Figure 29: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), China, 2010-2017 48
Figure 30: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), India, 2010-2017 49
Figure 31: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Stage of Development, 2000-2009 51
Figure 32: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Major Sponsors, 2000-2009 52
Figure 33: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Geography, 2000-2009 53
Figure 34: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials per Year, 2000-2009 54
Figure 35: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited by Stage of Development, 2000-2009 55
Figure 36: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients recruited by Major Sponsors, 2000-2009 56
Figure 37: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited by Geography, 2000-2009 57
Figure 38: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited per Year, 2000-2009 58
Figure 39: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Average Number of Patients Recruited per Trial by Stage of Development,2000-2009 59
Figure 40: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Average Number of Patients Recruited per Trial per Year, 2000-2009 60
Figure 41: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Prevalence Population (in Thousands), Brazil, 2010-2017 61
Figure 42: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Prevalence Population (in Thousands), China, 2010-2017 62
Figure 43: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Prevalence Population (in Thousands), India, 2010-2017 63
Figure 44: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Stage of Development, 2000-2009 65
Figure 45: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Major Sponsors, 2000-2009 66
Figure 46: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Geography, 2000-2009 67
Figure 47: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials per Year, 2000-2009 68
Figure 48: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Stage of Development, 2000-2009 69
Figure 49: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Major Sponsors, 2000-2009 70
Figure 50: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Geography, 2000-2009 71
Figure 51: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited per Year, 2000-2009 72
Figure 52: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 73
Figure 53: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Average Number of Patients Recruited per Trial per Year, 2000-2009 74
Figure 54: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), Brazil, 2010-2017 75
Figure 55: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), China, 2010-2017 76
Figure 56: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), India, 2010-2017 77
Figure 57: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Stage of Development, 2000-2009 79
Figure 58: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Major Sponsors, 2000-2009 80
Figure 59: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Geography, 2000-2009 81
Figure 60: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials per Year, 2000-2009 82
Figure 61: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Stage of Development, 2000-2009 83
Figure 62: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Major Sponsors, 2000-2009 84
Figure 63: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Geography, 2000-2009 85
Figure 64: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited per Year, 2000-2009 86
Figure 65: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Average Number of Patients Recruited per Trial by Stage of Development,2000-2009 87
Figure 66: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Average Number of Patients Recruited per Trial per Year, 2000-2009 88
Figure 67: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), Brazil, 2010-2017 89
Figure 68: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), China, 2010-2017 90
Figure 69: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), India, 2010-2017 91
Companies Mentioned
To order this report:
Pathology Industry: Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Pathology Business News
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article